Company: PRME
Filing Date: 2025-07-30
Form Type: 8-K
Source: 0001628280-25-036705
Chunk: 4

Company: Prime Medicine, Inc.
Filing Date: 2025-07-30
Form: 8-K
Item: Item 9.01
Chunk 4
---
Item 9.01 - Financial Statements and Exhibits

(d) Exhibits

  Exhibit      Description                                                                  
   Number                                                                                   
 ────────────────────────────────────────────────────────────────────────────────────────────
     99.1      Corporate Presentation, dated July 2025                                      
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: July 30, 2025

  Prime Medicine, Inc.                               
  By:                       /s/ Allan Reine          
  Name:                     Allan Reine, M. D.       
  Title:                    Chief Executive Officer